

04 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/04/3286595/0/en/palvella-therapeutics-announces-first-patients-dosed-in-phase-2-lotu-trial-of-fast-track-designated-qtorin-rapamycin-for-clinically-significant-angiokeratomas.html

28 Apr 2026
// INDPHARMAPOST
https://www.indianpharmapost.com/medical-device/concept-medical-unveils-promising-3-year-data-for-sirolimus-balloon-therapy-19947

28 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/28/3282671/0/en/quoin-pharmaceuticals-provides-clinical-and-regulatory-update-for-qrx009-topical-rapamycin-development-programs.html

03 Apr 2026
// INDPHARMAPOST
https://www.indianpharmapost.com/medical-device/concept-medical-unveils-landmark-sirpad-trial-at-acc-2026-advancing-pad-treatment-19529

31 Mar 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sirpad-primary-results-confirm-the-safety-and-efficacy-of-sirolimus-coated-balloon-in-pad-302729708.html

16 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/16/3256160/0/en/Palvella-Therapeutics-Announces-Issuance-of-European-Patent-Covering-Anhydrous-Compositions-of-Rapamycin.html